OraSure Technologies Inc (OSUR)
5.50
-0.03
(-0.54%)
USD |
NASDAQ |
Apr 24, 16:00
5.495
0.00 (0.00%)
After-Hours: 20:00
OraSure Technologies Free Cash Flow: 131.28M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 131.28M |
| September 30, 2023 | 76.06M |
| June 30, 2023 | 49.96M |
| March 31, 2023 | -24.84M |
| December 31, 2022 | -111.11M |
| September 30, 2022 | -129.37M |
| June 30, 2022 | -161.83M |
| March 31, 2022 | -152.27M |
| December 31, 2021 | -83.50M |
| September 30, 2021 | -61.94M |
| June 30, 2021 | -39.05M |
| March 31, 2021 | -36.22M |
| December 31, 2020 | -23.12M |
| September 30, 2020 | -13.68M |
| June 30, 2020 | -9.129M |
| March 31, 2020 | 0.244M |
| December 31, 2019 | 0.49M |
| September 30, 2019 | 16.75M |
| June 30, 2019 | 22.45M |
| March 31, 2019 | 24.91M |
| December 31, 2018 | 32.75M |
| September 30, 2018 | 15.79M |
| June 30, 2018 | 13.13M |
| March 31, 2018 | 17.82M |
| December 31, 2017 | 23.82M |
| Date | Value |
|---|---|
| September 30, 2017 | 25.48M |
| June 30, 2017 | 26.37M |
| March 31, 2017 | 28.84M |
| December 31, 2016 | 20.24M |
| September 30, 2016 | 20.48M |
| June 30, 2016 | 30.61M |
| March 31, 2016 | 22.21M |
| December 31, 2015 | 12.03M |
| September 30, 2015 | 11.71M |
| June 30, 2015 | 12.34M |
| March 31, 2015 | 5.808M |
| December 31, 2014 | 4.521M |
| September 30, 2014 | 16.79M |
| June 30, 2014 | 3.908M |
| March 31, 2014 | 5.762M |
| December 31, 2013 | 5.923M |
| September 30, 2013 | -6.822M |
| June 30, 2013 | -14.74M |
| March 31, 2013 | -13.88M |
| December 31, 2012 | -7.392M |
| September 30, 2012 | -5.022M |
| June 30, 2012 | -6.972M |
| March 31, 2012 | -4.229M |
| December 31, 2011 | -5.499M |
| September 30, 2011 | -3.702M |
Free Cash Flow Range, Past 5 Years
-161.83M
Minimum
Jun 2022
131.28M
Maximum
Dec 2023
-28.88M
Average
-23.12M
Median
Dec 2020
Free Cash Flow Benchmarks
| Abbott Laboratories | 5.059B |
| Integra Lifesciences Holdings Corp | 73.09M |
| Insulet Corp | 36.50M |
| Perspective Therapeutics Inc | -37.98M |
| Xtant Medical Holdings Inc | -10.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 41.37M |
| Cash from Investing (Quarterly) | 30.55M |
| Cash from Financing (Quarterly) | -0.355M |
| Free Cash Flow Per Share (Quarterly) | 0.5347 |
| Free Cash Flow to Equity (Quarterly) | 40.08M |
| Free Cash Flow to Firm (Quarterly) | 40.08M |
| Free Cash Flow Yield | 32.19% |